logo

For the Inventor, By the Inventor

Hamburg, Germany

Evotec International Gmbh


USPTO Granted Patents = 16

% Expired Patents = 31.3



Trademarks = 2

Forward Citations = 2

Loading Chart...
Loading Chart...

50 inventors (with patents filed for the assignee):

goldMedal Holly Atton (3 out of 8 patents)

silverMedal Christopher John Brown (3 out of 26 patents)

bronzeMedal James Lindsay Carr (3 out of 4 patents)

4.  Daryl Simon Walter (3 out of 4 patents)

5.  Andreas Blum (3 out of 14 patents)

6.  Matthias Austen (3 out of 8 patents)

7.  Mohamad Sabbah (3 out of 3 patents)

8.  Dieter Wiedenmayer (2 out of 30 patents)

9.  Dirk Gottschling (2 out of 18 patents)

10.  Joerg P Hehn (2 out of 13 patents)

11.  Ulrike Burk (2 out of 4 patents)

12.  Jonathan Paul Shine (2 out of 2 patents)

13.  Scott Alexander Sadler (2 out of 2 patents)

14.  Serge Convers-Reignier (1 out of 5 patents)

15.  Armin Heckel (1 out of 63 patents)


16 patents:

1. 12715865 - Modulators of the integrated stress response pathway (2026-08-25),
2. 12600720 - Modulators of the integrated stress response pathway (2026-04-14),
3. 12595252 - INHIBITORS OF SARM1 (2026-04-07),
4. 12441720 - Modulators of the integrated stress response pathway (2025-10-14),
5. 12275796 - Interferon-associated antigen binding proteins and uses thereof (2025-04-14),
6. 12258338 - Modulators of the integrated stress response pathway (2025-03-25),
7. 11835433 - Non-invasive, in vitro functional tissue assay systems (2023-12-05),
8. 11786528 - Pyrazolopyrimidine compounds as adenosine receptor antagonists (2023-10-17),
9. 10370378 - Treatment of sleep disorders (2019-08-06),
10. 10167296 - Sulfoximine substituted quinazolines for pharmaceutical compositions (2019-01-01),
11. 10093660 - Sulfoximine substituted quinazolines for pharmaceutical compositions (2018-10-09),
12. 9708274 - Sulfoximine substituted quinazolines for pharmaceutical compositions (2017-07-18),
13. 9049849 - Screening methods for compounds useful for treating pancreatic dysfunction (2015-06-09),
14. 9029323 - Neurturin conjugates for pharmaceutical use (2015-05-12),
15. 8772233 - Method for promoting regeneration of pancreatic beta-cells by administering neurturin (2014-07-08),
Company Overview
Evotec International GmbH is a leading global biotechnology company headquartered in Hamburg, Germany. The organization specializes in drug discovery and development, offering a range of innovative solutions to pharmaceutical and biotechnology partners. Evotec focuses on various therapeutic areas, including central nervous system disorders, metabolic diseases, and oncology, leveraging advanced technologies and extensive expertise to drive the development of novel therapeutics. Its collaborative approach fosters partnerships that enhance research capabilities and accelerate the path to market.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

16 Patents

#65 in Hamburg

#2,621 in Germany

#37,788 in the World

Hamburg, DE
Hamburg, Germany

Evotec International Gmbh

Forward Citations = 2

50 inventors:

goldMedal Holly Atton (3 out of 8 patents)

silverMedal Christopher John Brown (3 out of 26 patents)

bronzeMedal James Lindsay Carr (3 out of 4 patents)

4.  Daryl Simon Walter (3 out of 4 patents)

5.  Andreas Blum (3 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Evotec International Gmbh. Retrieved from https://idiyas.com/company/evotec-international

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…